Funded Startups in Altrincham
Of the seven most recent Altrincham-funded entries shown, the largest disclosed round is COMPASS Pathways at $200M (2026-02-26).
Of the seven most recent Altrincham-funded entries shown, the largest disclosed round is COMPASS Pathways at $200M (2026-02-26). That figure dwarfs the next-largest disclosed amounts in the same list: Cytospire Therapeutics at $83M (2026-05-05), Oak hill bio at $33M (2026-06-01), and FinalDose at $500K (2026-06-16), creating a long tail from multi‑$10M rounds down to the sub‑$1M floor.
The clustering is also time-driven: six of the seven rows fall between 2026-02-26 and 2026-06-16, and three separate companies record disclosed rounds on 2026-06-01 (Oak hill bio $33M in Biotechnology; ORBINOVA SOLUTIONS LIMITED shows “undisclosed” in Health Care). Sector concentration is pronounced with four of seven companies in Biotechnology (Oak hill bio, Cytospire Therapeutics, COMPASS Pathways, ORBINOVA SOLUTIONS LIMITED is Health Care but the three other entries in biotech still make up most of the visible list). Stage labels are mixed: three of seven entries are “Series Unknown,” one is “undisclosed,” and the remainder spans Pre-Seed (FinalDose), Seed (ORBINOVA SOLUTIONS LIMITED/Travel Seen), and Series A (Oak hill bio, Cytospire Therapeutics).
Most recent rounds
7 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Altrincham list, and how does it compare to the rest of the disclosed amounts?
COMPASS Pathways’ $200M disclosed round on 2026-02-26 is the clear outlier versus the next-largest disclosed amounts: Cytospire Therapeutics at $83M (2026-05-05) and Oak hill bio at $33M (2026-06-01). The remaining disclosed rounds include $8M (MoneyPlus Group, 2022-11-07) and $2M (Travel Seen, 2021-10-12), with FinalDose at just $500K (2026-06-16).
Are the most recent fundings clustered in a narrow window, or spread out over time?
They’re heavily clustered near the top of the date range: six of the seven rows are dated between 2026-02-26 (COMPASS Pathways) and 2026-06-16 (FinalDose). The only older entries are MoneyPlus Group at $8M (2022-11-07) and Travel Seen at $2M (2021-10-12).
Which city pattern shows up, given all rows are labeled Altrincham?
All seven entries are listed in Altrincham, Cheshire, United Kingdom, with no alternates (e.g., different Cheshire towns) in the visible rows. That means the geographic dispersion within the table is effectively zero on the city field, and differences show up instead in sector and stage labels.
How much of the list is concentrated in a single sector, and which companies drive it?
Biotechnology dominates in this slice: three of the seven companies are explicitly labeled Biotechnology (Oak hill bio $33M on 2026-06-01; Cytospire Therapeutics $83M on 2026-05-05; COMPASS Pathways $200M on 2026-02-26). The other sectors are Artificial Intelligence (FinalDose, $500K on 2026-06-16), Financial Services (MoneyPlus Group, $8M on 2022-11-07), Health Care (ORBINOVA SOLUTIONS LIMITED, “undisclosed” on 2026-06-01), and Community and Lifestyle (Travel Seen, $2M on 2021-10-12).
Does the stage/labeling show a pattern, especially around “Series Unknown” and undisclosed amounts?
Stage classification is a major pattern in this table: three of seven entries are marked “Series Unknown” (COMPASS Pathways $200M on 2026-02-26; MoneyPlus Group $8M on 2022-11-07; Travel Seen is Seed, so not included), and one entry is explicitly “undisclosed” (ORBINOVA SOLUTIONS LIMITED on 2026-06-01). The remaining stages visible are Pre-Seed (FinalDose, 2026-06-16) and Seed/Series A among the disclosed rounds (Travel Seen Seed at $2M; Oak hill bio and Cytospire Therapeutics are Series A at $33M and $83M).
Which entries look like outliers on both size and recency?
On the low end, FinalDose at $500K (2026-06-16) is far below the other disclosed amounts, while the high-end outlier is COMPASS Pathways at $200M (2026-02-26). Recency-wise, the only older disclosed amounts are MoneyPlus Group at $8M (2022-11-07) and Travel Seen at $2M (2021-10-12), both well behind the dense 2026 cluster.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.